Evidence-based (S3) guideline for the treatment of psoriasis vulgaris - Update: "Therapeutic options" and "Efalizumab".

Source:http://linkedlifedata.com/resource/pubmed/id/20096063

Download in:

View as

General Info

PMID
20096063